News Updates  

 The next Public Board Meeting will be on   Wednesday, March 21, 2018 at 9:30 AM at the Board of Pharmacy

COMAR 10.34.40 Pharmacists Prescribing Contraceptives
 Publication date in the Maryland Register 
February 16, 2018 
Public comments may be sent to Michele Phinney, Director, Office of Regulation and Policy Coordination, Maryland Department of Health, 201 West Preston Street, Room 512, Baltimore, MD 21201, or call 410.767.6499;
TTY: 800.735.2258, or email to, or fax to 410.767.6483. Comment will be accepted through March 19, 2018. A public hearing has not been scheduled.

The U.S. Food and Drug Administration (FDA) is requiring safety labeling changes for prescription cough and cold medicines containing codeine or hydrocodone (click here for more)


Click here for more information.

June 1, 2017
Maryland Pharmacist Naloxone Standing Order

Maryland Opioid Operational Command Center Alert:
Counterfeit Oxycodone Tablets Containing Fentanyl

Maryland Opioid Operational Command Center Alert: Carfentanil Overdose Deaths
Click Here for More

 CJIS Fees Effective Oct. 1 2016




​​​​Employees Only Site